Purdue and Amneal OxyContin clash ends
Pureradiancephoto / iStockphoto.com
Drugs company Purdue Pharma has filed a complaint against US-based generics company Amneal Pharmaceuticals for alleged patent infringement.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Purdue Pharma, Amneal, Oxycontin, ANDA, FDA, patent, patent infringement,